The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease
- 1 August 2000
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 109 (3) , 224-237
- https://doi.org/10.1016/s0002-9343(00)00474-5
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Platelet Glycoprotein IIb/IIIa AntagonistsCirculation, 1999
- EptifibatideDrugs, 1999
- LamifibanDrugs, 1999
- Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and α v β 3 IntegrinsCirculation, 1998
- TirofibanDrugs, 1998
- AbciximabDrugs, 1998
- Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery diseaseEuropean Heart Journal, 1996
- Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular MedicineNew England Journal of Medicine, 1995
- Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitorsJournal of Medicinal Chemistry, 1992
- A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.Journal of Clinical Investigation, 1985